You are here:
NICE
NICE Guidance
Conditions and diseases
Musculoskeletal conditions
Arthritis
Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis
Technology appraisal guidance
Reference number:
TA199
Published:
25 August 2010
Guidance
Tools and resources
Information for the public
Evidence
History
Research recommendations coming out of this guidance
There are no research recommendations for TA199